Ageing - Pipeline Insight, 2018

"Ageing - Pipeline Insight, 2018 report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ageing development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
Clinical
Non-clinical
Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Ageing
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Ageing
The report assesses the active Ageing pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsights team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
The report provides a snapshot of the pipeline development for the Ageing
The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Ageing
The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ageing
The report also covers the dormant and discontinued pipeline projects related to the Ageing

Reasons to Buy
Establish comprehensive understanding of the pipeline activity across this Ageing to formulate effective R&D strategies
Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Ageing therapeutics
Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress
1. Report Introduction
2. Ageing Overview
3. Pipeline Therapeutics
An Overview of Pipeline Products for Ageing
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
7. Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List Of Tables

Table 1: Total Products for Ageing
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List Of Figures

Figure 1: Total Products for Ageing
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

North America Anti Ageing Drugs Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Anti Ageing Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Global Anti Ageing Drugs Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of Anti Ageing Drugs is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

USD 4000 View Report

Respiratory Syncytial Virus Attachment Glycoprotein - Pipeline Review, H2 2019

Respiratory Syncytial Virus Attachment Glycoprotein - Pipeline Review, H2 2019Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) pipeline Target constitutes close to 7 molecules. The latest report Respiratory Syncytial

USD 3500 View Report

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019According to the recently published report Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019; Interleukin 1 Receptor

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available